AstraZeneca announced that the samples from test batches of the Covid-19 vaccine made by Siam Bioscience had passed the quality testing at AstraZeneca’s designated laboratories in Europe and US.
James Teague, Country President, AstraZeneca (Thailand) Ltd, said: “We have seen significant and promising progress in AstraZeneca’s Covid-19 vaccine development in Thailand during the past weeks.
“First, the Thai Food and Drug Administration approved Siam Bioscience as a manufacturing facility for the AstraZeneca Covid-19 vaccine.
“Last week, the samples of vaccines made by Siam Bioscience passed the full tests set by the Department of Medical Sciences (DMS) for requirements such as chemical composition and safety.
“And today, I am happy to be able to inform you that the samples from test batches of the Covid-19 vaccine made by Siam Bioscience has passed the quality testing at AstraZeneca’s designated laboratories in Europe and in the US.
“These significant progresses mean that we are getting closer to deliver the first batch of the vaccine to the government of Thailand.”
Numerous safety tests and quality control measures are carried out at each step of manufacturing and distribution. — The Nation/ANN